You are here
SBIR PHASE II - 1,136,508YR 1: BASE: 548,090, PARTIALLY FUNDED AT 430,000 (BALANCE TO BE FUNDED: 118,090)YR 2: OPTION: 588,418
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: N44AA120001
Agency Tracking Number: N44AA120001
Amount:
$548,090.00
Phase:
Phase II
Program:
SBIR
Solicitation Topic Code:
NIAAA
Solicitation Number:
N/A
Timeline
Solicitation Year:
2012
Award Year:
2012
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
675 ARAPEEN DRIVE, SUITE 302
SALT LAKE CITY, UT
84108-
United States
DUNS:
179151188
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: PAUL NEILSEN
Phone: (801) 588-0455
Email: PNEILSEN@ECHELON-INC.COM
Phone: (801) 588-0455
Email: PNEILSEN@ECHELON-INC.COM
Business Contact
Name: PAUL NEILSEN
Phone: (801) 588-0455
Email: PNEILSEN@ECHELON-INC.COM
Phone: (801) 588-0455
Email: PNEILSEN@ECHELON-INC.COM
Research Institution
Name: Stub
Abstract
There needs to better biomarkers of alcohol consumption and alcohol induced organ damage. PEth is a nonoxidative, long-lasting metabolite of ethanol consumption and alcohol related organ damage. PEth may also play a role in cell and organ damage. In this contract antibodies are made to PEth for ELISA research. A cell-based clinical assay for rapid quantification of PEth from blood samples will be generated. This ethanol biomarker assay should then be validated to identify heavy to moderate drinkers.
* Information listed above is at the time of submission. *